Ignite Creation Date:
2024-05-06 @ 1:40 AM
Last Modification Date:
2024-10-26 @ 11:07 AM
Study NCT ID:
NCT01867996
Status:
COMPLETED
Last Update Posted:
2017-05-11
First Post:
2013-05-30
Brief Title:
A Study to Evaluate the Pharmacokinetics Safety and Tolerability of Retosiban GSK221149 When Dosed With Efavirenz EFZ
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Organization Data
Organization:
GlaxoSmithKline
Class:
INDUSTRY
Study ID:
116073
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
GlaxoSmithKline
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None